230 related articles for article (PubMed ID: 24699306)
41. Heparanase enhances the insulin receptor signaling pathway to activate extracellular signal-regulated kinase in multiple myeloma.
Purushothaman A; Babitz SK; Sanderson RD
J Biol Chem; 2012 Nov; 287(49):41288-96. PubMed ID: 23048032
[TBL] [Abstract][Full Text] [Related]
42. Upregulation of heparanase in high-glucose-treated endothelial cells promotes endothelial cell migration and proliferation and correlates with Akt and extracellular-signal-regulated kinase phosphorylation.
Yuan L; Hu J; Luo Y; Liu Q; Li T; Parish CR; Freeman C; Zhu X; Ma W; Hu X; Yu H; Tang S
Mol Vis; 2012; 18():1684-95. PubMed ID: 22773906
[TBL] [Abstract][Full Text] [Related]
43. Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis.
Ejaeidi AA; Craft BS; Puneky LV; Lewis RE; Cruse JM
Exp Mol Pathol; 2015 Aug; 99(1):163-72. PubMed ID: 26079660
[TBL] [Abstract][Full Text] [Related]
44. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
45. Aspirin inhibits proliferation and induces apoptosis of multiple myeloma cells through regulation of Bcl-2 and Bax and suppression of VEGF.
Ding JH; Yuan LY; Huang RB; Chen GA
Eur J Haematol; 2014 Oct; 93(4):329-39. PubMed ID: 24766194
[TBL] [Abstract][Full Text] [Related]
46. Post-transcriptional regulation of heparanase gene expression by a 3' AU-rich element.
Arvatz G; Barash U; Nativ O; Ilan N; Vlodavsky I
FASEB J; 2010 Dec; 24(12):4969-76. PubMed ID: 20798248
[TBL] [Abstract][Full Text] [Related]
47. Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression.
Blich M; Golan A; Arvatz G; Sebbag A; Shafat I; Sabo E; Cohen-Kaplan V; Petcherski S; Avniel-Polak S; Eitan A; Hammerman H; Aronson D; Axelman E; Ilan N; Nussbaum G; Vlodavsky I
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):e56-65. PubMed ID: 23162016
[TBL] [Abstract][Full Text] [Related]
48.
Chiu HM; Chiou WY; Hsu WJ; Wu LH; Yang MH; Tyan YC; Lee CH
Int J Med Sci; 2021; 18(13):2981-2989. PubMed ID: 34220326
[No Abstract] [Full Text] [Related]
49. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
50. PG545, a heparan sulfate mimetic, reduces heparanase expression in vivo, blocks spontaneous metastases and enhances overall survival in the 4T1 breast carcinoma model.
Hammond E; Brandt R; Dredge K
PLoS One; 2012; 7(12):e52175. PubMed ID: 23300607
[TBL] [Abstract][Full Text] [Related]
51. Role of heparanase 2 (Hpa2) in gastric cancer.
Liu J; Knani I; Gross-Cohen M; Hu J; Wang S; Tang L; Ilan N; Yang S; Vlodavsky I
Neoplasia; 2021 Sep; 23(9):966-978. PubMed ID: 34343822
[TBL] [Abstract][Full Text] [Related]
52. Targeting heparanase to the mammary epithelium enhances mammary gland development and promotes tumor growth and metastasis.
Boyango I; Barash U; Fux L; Naroditsky I; Ilan N; Vlodavsky I
Matrix Biol; 2018 Jan; 65():91-103. PubMed ID: 28916201
[TBL] [Abstract][Full Text] [Related]
53. The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy.
Yang Y; MacLeod V; Dai Y; Khotskaya-Sample Y; Shriver Z; Venkataraman G; Sasisekharan R; Naggi A; Torri G; Casu B; Vlodavsky I; Suva LJ; Epstein J; Yaccoby S; Shaughnessy JD; Barlogie B; Sanderson RD
Blood; 2007 Sep; 110(6):2041-8. PubMed ID: 17536013
[TBL] [Abstract][Full Text] [Related]
54. Heparanase cooperates with Ras to drive breast and skin tumorigenesis.
Boyango I; Barash U; Naroditsky I; Li JP; Hammond E; Ilan N; Vlodavsky I
Cancer Res; 2014 Aug; 74(16):4504-14. PubMed ID: 24970482
[TBL] [Abstract][Full Text] [Related]
55. Heparanase coagulation and cancer progression.
Nadir Y; Brenner B
Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275
[TBL] [Abstract][Full Text] [Related]
56. Elevated Translation Initiation Factor eIF4E Is an Attractive Therapeutic Target in Multiple Myeloma.
Li S; Fu J; Lu C; Mapara MY; Raza S; Hengst U; Lentzsch S
Mol Cancer Ther; 2016 Apr; 15(4):711-9. PubMed ID: 26939700
[TBL] [Abstract][Full Text] [Related]
57. As
Wu D; Dong W; Fang K; Wang M
Technol Cancer Res Treat; 2019; 18():1533033819896806. PubMed ID: 31868118
[TBL] [Abstract][Full Text] [Related]
58. Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction.
Bakhashab S; Ahmed FW; Schulten HJ; Bashir A; Karim S; Al-Malki AL; Gari MA; Abuzenadah AM; Chaudhary AG; Alqahtani MH; Lary S; Ahmed F; Weaver JU
Cardiovasc Diabetol; 2016 Feb; 15():27. PubMed ID: 26861446
[TBL] [Abstract][Full Text] [Related]
59. Microvesicles shed from bortezomib-treated or lenalidomide-treated human myeloma cells inhibit angiogenesis in vitro.
Guo HM; Sun L; Yang L; Liu XJ; Nie ZY; Luo JM
Oncol Rep; 2018 Jun; 39(6):2873-2880. PubMed ID: 29693175
[TBL] [Abstract][Full Text] [Related]
60. Macrophage polarization in pancreatic carcinoma: role of heparanase enzyme.
Hermano E; Meirovitz A; Meir K; Nussbaum G; Appelbaum L; Peretz T; Elkin M
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25326645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]